sequencing-based diagnostics Adaptive Bio Narrows 2022 Revenue Guidance, Outlines Financial Expectations Releasing Q3 results, the Seattle-based immune system biotechnologies firm set its new full-year revenue guidance to the range of $185 million to $190 million. Adaptive Biotechnologies Inks Partnership to Integrate MRD Assay With Epic's EMR System After the expected integration in 2023, providers can order Adaptive’s ClonoSeq assay and review the results using the Epic electronic medical record system. Adaptive Biotechnologies Halts T-Detect Commercialization, Reports 13 Percent Q2 Revenue Growth Premium The company realized it is costly to develop single-disease T-Detect assays and is deferring commercialization until a clear path to reimbursement is proven. Adaptive Biotechnologies Looks to Refocus T-Cell Profiling Tech in Wake of Restructuring Premium Although it has seemingly tried to do everything, everywhere, all at once with its immune sequencing technology, Adaptive has sharpened its focus. Sequentify Raises $7M, Exits Stealth Mode The Israeli genomic sequencing startup claimed its proprietary technology can condense NGS sample preparation time to 3.5 hours from DNA to sequencing. May 5, 2022 Adaptive Biotechnologies Making Inroads in MRD, Immune Medicine Businesses Premium May 4, 2022 Adaptive Biotechnologies Q1 Revenues Rise Slightly in Q1 Feb 18, 2022 Pathogenomix Developing Infectious Disease Testing Platform Enabled by Cloud-Based Analytics, NGS Premium Feb 16, 2022 Adaptive Biotechnologies to Focus on Immune Medicine, Minimal Residual Disease Testing Businesses Premium Feb 15, 2022 Adaptive Biotechnologies Revenues Rise 26 Percent in Q4, 57 Percent in 2021 Aug 16, 2021 Clarified Precision Medicine Acquires Molecular Diagnostics Firm Interpares Biomedicine May 11, 2021 Caris Life Sciences Raises $830M to Support Precision Medicine Platform, Liquid Biopsy Development May 6, 2021 NantHealth Q1 Revenues Decline 11 Percent Apr 19, 2021 Korean Rare Disease Diagnostics Firm 3billion Looks to 2022 IPO, Expansion Into Drug Discovery Premium Mar 26, 2021 Rare Disease Screening Firm 3billion Closes $13M Series C Financing Mar 24, 2021 Twist Bioscience, Biotia Nab FDA EUA for Hybridization-Based NGS SARS-CoV-2 Assay Mar 16, 2021 Illumina, Geneseeq Technology to Collaborate on IVD Cancer Testing Kits in China Feb 25, 2021 NantHealth Q4 Revenues Flat From Year Ago Feb 25, 2021 Adaptive Biotechnologies Touts New Era of T Cell-Based Dx With T-Detect COVID Launch Premium Feb 24, 2021 Adaptive Biotechnologies Q4 Revenues Rise 25 Percent Feb 16, 2021 Fulgent Genetics, BioIQ Partner on NGS-Based SARS-CoV-2 Variant Detection Feb 8, 2021 Illumina Adds Nine Startups to Accelerator Program, Announces £20M Matching Fund Feb 2, 2021 Congenica, Gabriel Precision Oncology Partner on Clinical Interpretation for Somatic Cancer Testing Jan 21, 2021 Molzym, Fraunhofer Developing Rapid Direct-From-Sample Sepsis Diagnostic Platform and Test Premium Jan 14, 2021 Pacific Biosciences CEO Discusses Q4 Results, New Sequencing Platforms at JP Morgan Load More Breaking News Simple HealthKit Raises $8M in Series A Round Top Five Articles on GenomeWeb Last Week: Quantum-Si Layoffs, UBS Coverage Initiations, More LumiraDx Secures FDA Emergency Use Authorization, UK Approval for COVID-19, Flu Test Rarity Bioscience Raises Additional €500,000 Cancer Prognoses Informed by Module-Based Approach, Study Finds The Scan UK Team Presents Genetic, Epigenetic Sequencing Method Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers. DNA Biobank Developed for French Kidney Donors, Recipients The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France. Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site. Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.